Ramón VILLAVERDE GONZÁLEZ

Candeliere-Merlicco A, Villaverde-Gonzalez R, Hidalgo-Perez PV, Escobar-Arias FH, Aparicio-Castro E, Lastres-Arias MC. Dimethyl fumarate induced Wells syndrome. A case report. Rev Neurol. 2023 May 16;76(10):337-339. doi: 10.33588/rn.7610.2022323. PubMed PMID: 37165530; PubMed Central PMCID: PMC10478105.

AÑO: 2023; IF: 1.2

37165530

Meca-Lallana JE, Prieto Gonzalez JM, Caminero Rodriguez AB, Olascoaga Urtaza J, Alonso AM, Duran Ferreras E, Espinosa R, Dotor J, Romera M, Ares Luque A, Perez Ruiz D, Calles C, Hernandez MA, Hervas Garcia M, Mendoza Rodriguez A, Berdei Montero Y, Tellez N, Herrera Varo N, Sotoca J, Presas-Rodriguez S, Querol Gutierrez LA, Hervas Pujol M, Batlle Nadal J, Martin Ozaeta G, Gubieras Lillo L, Martinez Yelamos S, Ramio-Torrenta L, Mallada Frechin J, Belenguer Benavides A, Gascon-Gimenez F, Casanova B, Landete Pascual L, Berenguer L, Navarro L, Gomez Gutierrez M, Duran C, Rodriguez Regal A, Alvarez E, Garcia-Estevez DA, Lopez Real AM, Llaneza Gonzalez MA, Marzo Sola ME, Sanchez-Menoyo JL, Oterino A, Villaverde Gonzalez R, Castillo-Trivino T, Alvarez de Arcaya A, Llarena C. Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study. Neurol Ther. 2023 Dec;12(6):2177-2193. doi: 10.1007/s40120-023-00557-7. Epub 2023 Oct 20. PubMed PMID: 37861931; PubMed Central PMCID: PMC10630277.

AÑO: 2023; IF: 3.7

37861931

Villaverde-Gonzalez R. Updated Perspectives on the Challenges of Managing Multiple Sclerosis During Pregnancy. Degener Neurol Neuromuscul Dis. 2022 Jan 5;12:1-21. doi: 10.2147/DNND.S203406. eCollection 2022. PubMed PMID: 35023987; PubMed Central PMCID: PMC8743861.

AÑO: 2022

35023987

Fernandez-Diaz E, Perez-Vicente JA, Villaverde-Gonzalez R, Berenguer-Ruiz L, Candeliere Merlicco A, Martinez-Navarro ML, Gracia Gil J, Romero-Sanchez CM, Alfaro-Saez A, Diaz I, Gimenez-Martinez J, Mendez-Miralles MA, Millan-Pascual J, Jimenez-Pancho J, Mola S, Sempere AP. Real-world experience of ocrelizumab in multiple sclerosis in a Spanish population. Ann Clin Transl Neurol. 2021 Feb;8(2):385-394. doi: 10.1002/acn3.51282. Epub 2020 Dec 25. PubMed PMID: 33369288; PubMed Central PMCID: PMC7886031.

AÑO: 2021; IF: 5.43

33369288

Villaverde-González R, Candeliere-Merlicco A, Alonso-Frías MA, Aparicio Castro E, Carrillo Alcaraz A, Mallada Frechín J, Pérez Sempere Á. Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study. Mult Scler Relat Disord. 2020 Nov;46:102518. doi: 10.1016/j.msard.2020.102518. Epub 2020 Sep 16. PubMed PMID: 32977075.

AÑO: 2020; IF: 4.339

32977075